Zuranolone (Zurzuvae)

Type: drug

Status: FDA Approved (PPD)

Developer: Sage/Biogen

Breakthrough Summary

No summary available.

Mechanism of Action

Oral neuroactive steroid for postpartum depression

Year: 2023